Cellosaurus logo
expasy logo

Cellosaurus BT 245 (CVCL_IP13)

[Text version]
Cell line name BT 245
Synonyms BT-245; BT245; BCH245; Boston Children's Hospital 245
Accession CVCL_IP13
Resource Identification Initiative To cite this cell line use: BT 245 (RRID:CVCL_IP13)
Comments Characteristics: Low-passage-number culture.
Characteristics: Grows as neurospheres in suspension (Millipore=SCC219).
Derived from site: In situ; Brain; UBERON=UBERON_0000955.
Sequence variations
Disease Glioblastoma (NCIt: C3058)
Glioblastoma (ORDO: Orphanet_360)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling Children
Category Cancer cell line
STR profile Source(s): Millipore=SCC219

Markers:
AmelogeninX,Y
CSF1PO12
D3S135818
D5S81812
D7S8208,10
D8S117911,13
D13S31711
D16S53911
D18S5114
D21S1131.2
FGA19
Penta D12
Penta E14
TH019
TPOX8,12
vWA14,15

Run an STR similarity search on this cell line
Publications

PubMed=25366336; DOI=10.1093/neuonc/nou303; PMCID=PMC4482855
Green A.L., Ramkissoon S.H., McCauley D., Jones K., Perry J.A., Hsu J.H.-R., Ramkissoon L.A., Maire C.L., Hubbell-Engler B., Knoff D.S., Shacham S., Ligon K.L., Kung A.L.-J.
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Neuro-oncol. 17:697-707(2015)

Patent=US20200384022
Suva M.L., Bernstein B.E., Regev A., Filbin M.G., Tirosh I., Hovestadt V.
Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas.
Patent number US20200384022, 10-Dec-2020

Cross-references
Cell line collections (Providers) Millipore; SCC219
Cell line databases/resources cancercelllines; CVCL_IP13
Anatomy/cell type resources BTO; BTO_0005952
Chemistry resources PharmacoDB; BT245_130_2019
Encyclopedic resources Wikidata; Q54798426
Entry history
Entry creation03-Mar-2017
Last entry update19-Dec-2024
Version number11